Ning Lin, MD
Neurosurgery · New York, NYNPI 1538210042
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,356 of the $4,163 with a category attached, or 80.6%. 9 manufacturers reported payments, led by Stryker at 29.1% of the total. Reporting peaked in 2019 at $1,947 and has fallen 91.1% since, to $173 in 2025.
Across 62 payments — averaging $67.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Microvention, Inc.$1K
- Medtronic$829
- Penumbra, Inc.$589
- Johnson & Johnson$226
- Lifenet Health$103
- plus $125 from 3 others
What the payments were for
- Travel & lodging$80719%
- Food & beverage$3,35681%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 34 | $1,213 |
| Microvention, Inc. | 4 | $1,078 |
| Medtronic(2 entities) | 9 | $829 |
| Penumbra, Inc. | 7 | $589 |
| Johnson & Johnson | 4 | $226 |
| Lifenet Health | 1 | $103 |
| Zimmer Biomet | 1 | $60 |
| Globus Medical | 1 | $36 |
| Imperative Care, Inc | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WEB$772
- RED 72$428
- DELTA SYSTEM 1.7/2.2$297
- WEB Aneurysm Embolization System$271
- StealthStation$223
- EVOLVE PROLINE$158
- OSTEOCOOL RF ABLATION$150
- O-ARM-Spine$134
- MAZOR X SYSTEM$114
- Allograft VMIS Delivery System$103
How this compares
Too few neurosurgery providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 11 | $252 |
| Gabapentin | 19 | $227 |
| Ibuprofen | 13 | $114 |
Paid to pharmacies, not to this prescriber.
Other neurosurgery in New York
- Joshua BedersonNew York$12K
- Tanvir ChoudhriNew York$4K
- Isabelle GermanoNew York$4K
- Ori BarzilaiNew York$3K
- Caitlin HoffmanNew York$510
- Roee BerNew York$0
- David AltschulBronx$440K
- Alexandra PaulAlbany$90K
- Benjamin CohenRockville Centre$19K
- William SonsteinRockville Centre$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.